1. Cirz, R.T., Chin, J.K., Andes, D.R., et al., Inhibition of mutation and combating the evolution of antibiotic resistance, PLoS Biol., 2005, vol. 3, no. 6, pp. 1024–1033. doi 10.1371/journal.pbio.0030176
2. Diver, J.M., Quinolone uptake by bacteria and bacterial killing, Rev. Infect. Dis., 1989, vol. 11, no. 5, pp. 941–946.
3. Drlica, K., Malik, M., Kerns, R.J., and Zhao, X., Quinolone-mediated bacterial death, Antimicrob. Agents Chemother., 2008, vol. 52, no. 2, pp. 385–392. doi 10.1128/AAC.01617-06
4. Bol’shakov, L.V., Variations in dioxidine susceptibility of clinical bacterial strains for the period from 1984 up to1988 years, Antibiot. Khimioter., 1990, vol. 35, no. 9, pp. 17–19.
5. Popov, D.A., Anuchina, N.M., Terent’ev, A.A., Kostyuk, G.V., Blatun, L.A., Rusanova, E.V., et al., Dioxidine: Antimicrobial activity and prospects for clinical usage nowadays, Antibiot. Khimioter., 2013, vol. 58, nos. 3–4, pp. 37–42.